Can-Fite BioPharma Ltd.
CANF
$3.39
$0.030.89%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -9.83M | -9.31M | -8.80M | -8.34M | -7.88M |
| Total Depreciation and Amortization | 24.00K | 26.50K | 29.00K | 18.00K | 7.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 422.00K | 438.50K | 455.00K | 479.00K | 503.00K |
| Change in Net Operating Assets | 433.00K | 197.50K | -38.00K | -152.50K | -267.00K |
| Cash from Operations | -8.95M | -8.65M | -8.35M | -8.00M | -7.64M |
| Capital Expenditure | -2.00K | -2.00K | -2.00K | -3.50K | -5.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 0.00 | 0.00 | 750.00K | 1.50M |
| Cash from Investing | -2.00K | -2.00K | -2.00K | 746.50K | 1.50M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 9.64M | 10.12M | 10.60M | 8.91M | 7.22M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -256.00K | -512.00K | -512.00K | -512.00K |
| Cash from Financing | 9.64M | 9.86M | 10.08M | 8.40M | 6.71M |
| Foreign Exchange rate Adjustments | 10.00K | 8.00K | 6.00K | -8.00K | -22.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 703.00K | 1.22M | 1.74M | 1.14M | 547.00K |